The role of the T3/antigen receptor complex is summarized by the diagram presented in Figure 4. Signals transmitted through T3/Ti activate a phosphodiesterase. This enzyme acts on its substrate PIP2 to generate two important mediators, IP3 and diacylglycerol. IP3 mobilizes calcium from bound intracellular stones. This increase in [Ca2+]i is one intracellular signal which, in conjunction with others, induces expression of lymphokine genes by influencing pretranslational, presumably transcriptional, events. Several problems remain. Which of the five molecules in the T3/Ti complex serves as the effector molecule in the transmembrane signaling process is not known. Which molecules serve to link T3/Ti to the phosphodiesterase enzyme is under investigation. The role diacylglycerol protein kinase C and other mediators play in signalling activation is not established. Finally, for those events occurring after the early events pictured in Figure 4 that result in gene activation, the sequence is a black box. Approaches to address each of these questions are available, and answers should be forthcoming.
Mutagenesis studies have demonstrated the requirement for the CD28-responsive element (CD28RE) within the interleukin-2 (IL-2) promoter for transcriptional upregulation by CD28. Here, we demonstrate that CD28 responsiveness is conferred by a composite element containing both the CD28RE and the NF-IL-2B AP-1 sites (RE/AP). Mutations at either site within the RE/AP composite element abolish activity. The RE/AP composite element is a site for signal integration within the IL-2 promoter, since its activation is dependent on at least two separate signalling pathways being activated, through the T-cell receptor, CD28, and/or phorbol myristate acetate. Activation is maximal when all three signals occur simultaneously. By using a panel of CD28 cytoplasmic domain mutants, it was found that the transcriptional activation of the RE/AP composite element correlates exactly with the pattern of IL-2 secretion induced by these mutants upon stimulation. Similar to the upregulation of IL-2 secretion, the transcriptional upregulation of the RE/AP composite element by CD28 is FK506 insensitive. The pattern of activation of the RE/AP composite element is different from that observed for either an NFAT or consensus AP-1 site, implying that RE/AP represents a unique element. Using gel shift analysis, we demonstrate that stimulation by CD28 induces the association of the NF-B family member c-Rel to the CD28RE within the RE/AP composite element. The transcriptional upregulation of IL-2 by CD28 appears, therefore, to be mediated through the RE/AP composite element, involving the association of c-Rel with the CD28RE.Activation of T cells by recognition of antigens and major histocompatibility complex products on the surfaces of antigen-presenting cells initiates a series of biochemical events leading to T-cell proliferation and cytokine secretion (33). Stimulation through the T-cell receptor (TCR) alone is insufficient for T-cell proliferation or interleukin-2 (IL-2) production. In the absence of costimulation, a state of unresponsiveness, termed anergy, may develop (13, 18). The failures to produce and respond to IL-2 are the major determinants of anergy. CD28, a 44-kDa glycoprotein expressed as a homodimer on most T cells, can mediate costimulation. Induction of anergy in T-cell clones was found to be blocked by activation of CD28 by monoclonal antibodies (7).One consequence of T-cell activation is the expression of IL-2, due to both transcriptional upregulation and stabilization of IL-2 mRNA. Transcriptional upregulation is mediated by the IL-2 promoter, contained within approximately 300 bp upstream from the transcriptional start site (reviewed in references 11 and 22). Engagement of CD28 enhances activation of the IL-2 promoter resulting from either TCR stimulation or use of phorbol esters such as phorbol myristate acetate (PMA). Mutagenesis studies have demonstrated that a CD28-responsive element (CD28RE), located within the IL-2 promoter between Ϫ160 and Ϫ152 relative to the transcriptional start site, is required for CD28-induced ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.